Cargando…
No improvement in the reporting of clinical trial subgroup effects in high-impact general medical journals
BACKGROUND: When subgroup analyses are not correctly analyzed and reported, incorrect conclusions may be drawn, and inappropriate treatments provided. Despite the increased recognition of the importance of subgroup analysis, little information exists regarding the prevalence, appropriateness, and st...
Autores principales: | Gabler, Nicole B., Duan, Naihua, Raneses, Eli, Suttner, Leah, Ciarametaro, Michael, Cooney, Elizabeth, Dubois, Robert W., Halpern, Scott D., Kravitz, Richard L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4947338/ https://www.ncbi.nlm.nih.gov/pubmed/27423688 http://dx.doi.org/10.1186/s13063-016-1447-5 |
Ejemplares similares
-
Dealing with heterogeneity of treatment effects: is the literature up to the challenge?
por: Gabler, Nicole B, et al.
Publicado: (2009) -
Active Choice Intervention Increases Advance Directive Completion: A
Randomized Trial
por: Josephs, Michael, et al.
Publicado: (2018) -
Conduct and Implementation of Personalized Trials in Research and Practice
por: Kravitz, Richard L., et al.
Publicado: (2022) -
Intuitive vs Deliberative Approaches to Making Decisions About Life Support: A Randomized Clinical Trial
por: Rubin, Emily B., et al.
Publicado: (2019) -
Does haste make waste? Prevalence and types of errors reported after publication of studies of COVID-19 therapeutics
por: Chatterton, Brittany, et al.
Publicado: (2023)